Ellipsoid Zone Integrity and Visual Acuity Changes during Diabetic Macular Edema Therapy: A Longitudinal Study

Ellipsoid Zone Integrity and Visual Acuity Changes during Diabetic Macular Edema Therapy: A Longitudinal Study

Purpose. Ellipsoid zone (EZ) integrity is identified as a potential biomarker for therapy surveillance and outcome prediction of visual acuity (VA). However, only a few studies report long-term results of over 1 year of clinical and anatomical changes in patients with diabetic macular edema (DME). T...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lucy J. Kessler, Gerd U. Auffarth, Dmitrii Bagautdinov, Ramin Khoramnia
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2021/8117650
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
by: Ying Zhang, et al.
Published: (2022-01-01)

Association between Visual Acuity and Retinal Layer Metrics in Diabetics with and without Macular Edema
by: LakshmiPriya Rangaraju, et al.
Published: (2018-01-01)

Pengaruh Bevacizumab Intravitreal terhadap Best Corrected Visual Acuity dan Central Macular Thickness pada Diabetic Macular Edema
by: Arini Ghaisa Atsari, et al.
Published: (2020-01-01)

Restoration of the Ellipsoid Zone and Visual Prognosis at 1 Year after Surgical Macular Hole Closure
by: Hiruma Hasebe, et al.
Published: (2016-01-01)

The Analysis of Correlative Factors of Visual Acuity with Intravitreal Conbercept Injection in Macular Edema Associated with Branch Retinal Vein Occlusion
by: Wenjuan Luo, et al.
Published: (2018-01-01)

Correlation of Macular Focal Electroretinogram with Ellipsoid Zone Extension in Stargardt Disease
by: Edoardo Abed, et al.
Published: (2017-01-01)

Combination of Navigated Macular Laser Photocoagulation and Anti-VEGF Therapy: Precise Treatment for Macular Edema under Dry Retinal Conditions
by: Ernest V. Boiko, et al.
Published: (2017-01-01)

Microperimetric Biofeedback Training Improved Visual Acuity after Successful Macular Hole Surgery
by: Tomoko Ueda-Consolvo, et al.
Published: (2015-01-01)

Correlation between ellipsoid zone thickness and the presence of subretinal drusenoid deposits in age-related macular degeneration
by: Richard B Rosen, et al.
Published: (2024-08-01)

Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity
by: Leila El Matri, et al.
Published: (2012-01-01)

Intravitreal Therapy for Diabetic Macular Edema: An Update
by: Claudio Furino, et al.
Published: (2021-01-01)

Predictive value of different baseline optical coherence tomography biomarkers for visual acuity changes in neovascular age-related macular degeneration
by: Hamid Riazi-Esfahani, et al.
Published: (2025-02-01)

Human Gaze Following Response Is Affected by Visual Acuity
by: Marcella Spoor, et al.
Published: (2014-01-01)

Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
by: Joachim Wachtlin, et al.
Published: (2020-01-01)

Impact of surgery on visual acuity and life quality of senile patients
by: Mariela Julia Curbelo Gómez, et al.
Published: (2009-09-01)

Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy
by: Sibel Doguizi, et al.
Published: (2015-01-01)

Cystoid Macular Edema in Bietti's Crystalline Retinopathy
by: Ali Osman Saatci, et al.
Published: (2014-01-01)

New Strategies for Treatment of Diabetic Macular Edema
by: Yoshihiro Takamura, et al.
Published: (2018-01-01)

Changes in Intraocular Straylight and Visual Acuity with Age in Cataracts of Different Morphologies
by: Sonia Gholami, et al.
Published: (2017-01-01)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
by: Filipe Mira, et al.
Published: (2017-01-01)

Prevalence, Demographics, and Treatment Characteristics of Visual Impairment due to Diabetic Macular Edema in a Representative Canadian Cohort
by: Robert J. Petrella, et al.
Published: (2012-01-01)

Ranibizumab for Visual Impairment due to Diabetic Macular Edema: Real-World Evidence in the Italian Population (PRIDE Study)
by: Ugo Menchini, et al.
Published: (2015-01-01)

Intraocular Lens Opacification following Intracameral Injection of Recombinant Tissue Plasminogen Activator to Treat Inflammatory Membranes after Cataract Surgery
by: Simon S. M. Fung, et al.
Published: (2015-01-01)

Driving Performance Evaluation Correlated to Age and Visual Acuities Based on VR Technologies
by: Sooncheon Hwang, et al.
Published: (2020-01-01)

Intravitreal Aflibercept as a Rescue Therapy for Retinal Neovascularization and Macular Edema due to Eales Disease
by: Ning-Yi Hsia, et al.
Published: (2021-01-01)

Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
by: Andrea Russo, et al.
Published: (2013-01-01)

Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory
by: Pedro Romero-Aroca, et al.
Published: (2016-01-01)

Comparison of the ellipsoid and simplex methods
by: Eligijus Laurinavičius, et al.
Published: (1999-12-01)

IMAGE PROCESSING AT ELLIPSOIDAL PHOTOMETRY
by: M. A. Bezuglyi, et al.
Published: (2016-06-01)

Optical Coherence Tomography Angiography of Macular Perfusion Changes after Anti-VEGF Therapy for Diabetic Macular Edema: A Systematic Review
by: Ayman G. Elnahry, et al.
Published: (2021-01-01)

Visual Acuity Outcomes and Influencing Factors in a Cohort of UK Real-World Diabetic Macular Oedema Patients During the First Two Years of Anti-VEGF Treatment
by: Qing Wen, et al.
Published: (2025-01-01)

Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema
by: Ningxin Dou, et al.
Published: (2021-01-01)

Assessment of Visual Acuity, Refraction Changes, and Proptosis in Different Ages of Patients with Thyroid Diseases
by: J. Jankauskiene, et al.
Published: (2012-01-01)

Systemic Factors Associated with Treatment Response in Diabetic Macular Edema
by: Wendy Meihua Wong, et al.
Published: (2020-01-01)

Renal Biomarkers for Treatment Effect of Ranibizumab for Diabetic Macular Edema
by: Ivan Pochou Lai, et al.
Published: (2020-01-01)

Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort
by: Robert J. Petrella, et al.
Published: (2012-01-01)

The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis of Randomized Controlled Trials
by: Li Xiaodong, et al.
Published: (2022-01-01)

Interocular Shift of Visual Attention Enhances Stereopsis and Visual Acuities of Anisometropic Amblyopes beyond the Critical Period of Visual Development: A Novel Approach
by: Liwen Huang, et al.
Published: (2014-01-01)

Rapid Recovery of Visual Acuity after Lumboperitoneal Shunt Operation in Malignant Idiopathic Intracranial Hypertension
by: Levent Sinan Bir, et al.
Published: (2011-01-01)

Severe Macular Edema in Patients with Juvenile Idiopathic Arthritis-Related Uveitis
by: Maria Pia Paroli, et al.
Published: (2013-01-01)